Cargando…

The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation

Deoxycholic Acid (DCA), which is an FDA-approved compound for the reduction of submental fat, has evolved through an unanticipated and surprising sequence of events. Initially, it was used as a solvent for Phosphatidylcholine (PDC), which was thought to promote lipolysis, but it was later proven to...

Descripción completa

Detalles Bibliográficos
Autores principales: Muskat, Ahava, Pirtle, Megan, Kost, Yana, McLellan, Beth N., Shinoda, Kosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988282/
https://www.ncbi.nlm.nih.gov/pubmed/35399925
http://dx.doi.org/10.3389/fendo.2022.841889
_version_ 1784682927275114496
author Muskat, Ahava
Pirtle, Megan
Kost, Yana
McLellan, Beth N.
Shinoda, Kosaku
author_facet Muskat, Ahava
Pirtle, Megan
Kost, Yana
McLellan, Beth N.
Shinoda, Kosaku
author_sort Muskat, Ahava
collection PubMed
description Deoxycholic Acid (DCA), which is an FDA-approved compound for the reduction of submental fat, has evolved through an unanticipated and surprising sequence of events. Initially, it was used as a solvent for Phosphatidylcholine (PDC), which was thought to promote lipolysis, but it was later proven to be the bioactive component of the formula and is currently widely used as Kybella. It has also been used off-label to treat other types of fat deposits like lipomas, HIV lipodystrophy, and excess orbital fat. Despite widespread clinical use, there has been no consensus clarifying the mechanisms of DCA and PDC alone or in combination. Furthermore, despite PDC’s removal from the FDA-approved formula, some studies do suggest it plays an important role in fat reduction. To provide some clarity, we conducted a PubMed search and reviewed 41 articles using a comprehensive list of terms in three main categories, using the AND operator: 1) Phosphatidylcholines 2) Deoxycholic Acid, and 3) Lipoma. We isolated articles that studied PDC, DCA, and a PDC/DCA compound using cell biology, molecular and genetic techniques. We divided relevant articles into those that studied these components using histologic techniques and those that utilized specific cell death and lipolysis measurement techniques. Most morphologic studies indicated that PDC/DCA, DCA, and PDC, all induce some type of cell death with accompanying inflammation and fibrosis. Most morphologic studies also suggest that PDC/DCA and DCA alone are non-selective for adipocytes. Biochemical studies describing PDC and DCA alone indicate that DCA acts as a detergent and rapidly induces necrosis while PDC induces TNF-α release, apoptosis, and subsequent enzymatic lipolysis after at least 24 hours. Additional papers have suggested a synergistic effect between the two compounds. Our review integrates the findings of this growing body of literature into a proposed mechanism of fat reduction and provides direction for further studies.
format Online
Article
Text
id pubmed-8988282
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89882822022-04-08 The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation Muskat, Ahava Pirtle, Megan Kost, Yana McLellan, Beth N. Shinoda, Kosaku Front Endocrinol (Lausanne) Endocrinology Deoxycholic Acid (DCA), which is an FDA-approved compound for the reduction of submental fat, has evolved through an unanticipated and surprising sequence of events. Initially, it was used as a solvent for Phosphatidylcholine (PDC), which was thought to promote lipolysis, but it was later proven to be the bioactive component of the formula and is currently widely used as Kybella. It has also been used off-label to treat other types of fat deposits like lipomas, HIV lipodystrophy, and excess orbital fat. Despite widespread clinical use, there has been no consensus clarifying the mechanisms of DCA and PDC alone or in combination. Furthermore, despite PDC’s removal from the FDA-approved formula, some studies do suggest it plays an important role in fat reduction. To provide some clarity, we conducted a PubMed search and reviewed 41 articles using a comprehensive list of terms in three main categories, using the AND operator: 1) Phosphatidylcholines 2) Deoxycholic Acid, and 3) Lipoma. We isolated articles that studied PDC, DCA, and a PDC/DCA compound using cell biology, molecular and genetic techniques. We divided relevant articles into those that studied these components using histologic techniques and those that utilized specific cell death and lipolysis measurement techniques. Most morphologic studies indicated that PDC/DCA, DCA, and PDC, all induce some type of cell death with accompanying inflammation and fibrosis. Most morphologic studies also suggest that PDC/DCA and DCA alone are non-selective for adipocytes. Biochemical studies describing PDC and DCA alone indicate that DCA acts as a detergent and rapidly induces necrosis while PDC induces TNF-α release, apoptosis, and subsequent enzymatic lipolysis after at least 24 hours. Additional papers have suggested a synergistic effect between the two compounds. Our review integrates the findings of this growing body of literature into a proposed mechanism of fat reduction and provides direction for further studies. Frontiers Media S.A. 2022-03-24 /pmc/articles/PMC8988282/ /pubmed/35399925 http://dx.doi.org/10.3389/fendo.2022.841889 Text en Copyright © 2022 Muskat, Pirtle, Kost, McLellan and Shinoda https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Muskat, Ahava
Pirtle, Megan
Kost, Yana
McLellan, Beth N.
Shinoda, Kosaku
The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation
title The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation
title_full The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation
title_fullStr The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation
title_full_unstemmed The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation
title_short The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation
title_sort role of fat reducing agents on adipocyte death and adipose tissue inflammation
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988282/
https://www.ncbi.nlm.nih.gov/pubmed/35399925
http://dx.doi.org/10.3389/fendo.2022.841889
work_keys_str_mv AT muskatahava theroleoffatreducingagentsonadipocytedeathandadiposetissueinflammation
AT pirtlemegan theroleoffatreducingagentsonadipocytedeathandadiposetissueinflammation
AT kostyana theroleoffatreducingagentsonadipocytedeathandadiposetissueinflammation
AT mclellanbethn theroleoffatreducingagentsonadipocytedeathandadiposetissueinflammation
AT shinodakosaku theroleoffatreducingagentsonadipocytedeathandadiposetissueinflammation
AT muskatahava roleoffatreducingagentsonadipocytedeathandadiposetissueinflammation
AT pirtlemegan roleoffatreducingagentsonadipocytedeathandadiposetissueinflammation
AT kostyana roleoffatreducingagentsonadipocytedeathandadiposetissueinflammation
AT mclellanbethn roleoffatreducingagentsonadipocytedeathandadiposetissueinflammation
AT shinodakosaku roleoffatreducingagentsonadipocytedeathandadiposetissueinflammation